Global Disposable Membrane Oxygenator Kit Market Strategic Research Report

Scope of the Report

The global Disposable Membrane Oxygenator Kit market size is predicted to grow from US$ 704 million in 2025 to US$ 1,019 million in 2032; it is expected to grow at a CAGR of 5.4% from 2026 to 2032.

A disposable membrane oxygenator kit is a sterile, single-use extracorporeal blood gas-exchange consumable centered on a hollow-fiber membrane oxygenator. It enables oxygen transfer and carbon dioxide removal through a gas-permeable membrane and may integrate a heat exchanger, venous reservoir, arterial filter, centrifugal pump head, pre-connected tubing, pressure or temperature sensors, gas lines and priming accessories depending on the intended clinical use. The product is used together with cardiopulmonary bypass equipment, ECMO/ECLS consoles or extracorporeal cardiopulmonary support systems, and is primarily applied in open-heart surgery, cardiopulmonary bypass, acute respiratory failure, acute cardiopulmonary failure, emergency life support, intensive care and transport extracorporeal support.

Based on our research, the disposable membrane oxygenator kit market should be understood as a clinically critical consumables segment spanning cardiopulmonary bypass and extracorporeal life support rather than as a single standardized product category. In cardiac surgery, the oxygenator is a mature, high-volume disposable used during short-duration cardiopulmonary bypass. In ECMO and ECLS, the product is more often configured as a pre-connected patient kit that may combine the oxygenator, pump head, tubing, sensors and gas lines. This difference is essential for market sizing, because CPB products usually have lower ASPs and broader installed use, while ECMO kits have lower unit volume but materially higher value per procedure.

Looking forward, growth is likely to be structurally stronger in ECMO/ECLS kits than in conventional CPB oxygenators. The most important product trends are plasma-resistant membranes, biocompatible coatings, lower priming volume, lower pressure drop, integrated filtration, safer pre-connected circuits and longer validated support duration. Policy-driven local manufacturing, post-pandemic critical care investment, transport ECMO programs and regional supply-chain localization will continue to support demand. However, revenue visibility remains limited because most companies disclose oxygenators within broader cardiopulmonary, perfusion, acute care or extracorporeal support portfolios rather than as a standalone financial line.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Disposable Membrane Oxygenator Kit market?

What factors are driving Disposable Membrane Oxygenator Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Disposable Membrane Oxygenator Kit market opportunities vary by end market size?

How does Disposable Membrane Oxygenator Kit break out by Type, by Application?

This report presents a comprehensive overview of the global Disposable Membrane Oxygenator Kit market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• CPB Circuit Pack
• Pump-Oxygenator Integrated Kit
• Other

Segment by Use Duration

• Intraoperative Short-term Use
• Short-term ECLS Use
• Prolonged ECLS Use
• Other

Segment by Patient Size / Flow Range

• Neonatal
• Pediatric
• Adult Standard Flow
• Adult High Flow

Segment by Coating / Surface Treatment

• Uncoated Oxygenator
• Heparin-coated Oxygenator
• Non-heparin Biocompatible Coating
• Other

Segment by Application

• Cardiopulmonary Bypass, CPB
• ECMO / ECLS
• ECCO2R / Partial Gas Exchange
• Other Clinical Gas Exchange

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Disposable Membrane Oxygenator Kit market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Cardiopulmonary Bypass, CPB, ECMO / ECLS, ECCO2R / Partial Gas Exchange evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact